Cantor Fitzgerald Initiates Coverage On Odyssey Therapeutics with Overweight Rating
Benzinga Newsdesk 5 months ago
NewsInitiationAnalyst Ratings
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Odyssey Therapeutics (NASDAQ:ODTX) with a Overweight rating.
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Odyssey Therapeutics (NASDAQ:ODTX) with a Overweight rating.